Autoimmunity to nucleosomes related to viral infection: A focus on hapten-carrier complex formation

Journal of Autoimmunity

Volumn 20, Issue 2, 2003, Pages 171-182

  Van Ghelue, Marijke ^a   Moens, Ugo ^a   Bendiksen, Signy ^a   Rekvig, Ole Petter ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Autoimmunity; DNA binding protein; Systemic lupus erythematosus; Virus

Indexed keywords

CD4 ANTIGEN; DNA BINDING PROTEIN; EPITOPE; GENOMIC RNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; BK VIRUS; CELLULAR IMMUNITY; CLINICAL STUDY; CROSS REACTION; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; HAPTEN CARRIER COMPLEX; HOST CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; JC VIRUS; MACROPHAGE; MOLECULAR MIMICRY; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REVIEW; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; VIRUS CAPSID; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS SHEDDING;

EID: 0037343829     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(02)00110-5     Document Type: Review

References (124)

1. Bar-Or A., Oliveira E.M., Anderson D.E., Hafler D.A. Molecular pathogenesis of multiple sclerosis. J Neuroimmunol. 100:1999;252-259.
2. Mathis D., Vence L., Benoist C. Cell death during progression to diabetes. Nature. 414:2001;792-798.
3. Whitton J.L., Fujinami R.S. Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol. 2:1999;392-397.
4. Lahita R.G. Systemic lupus erythematosus. 3rd ed. 1999;Academic Press, New York.
5. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol. 2:2001;777-780.
6. Kotzin B.L. Systemic lupus erythematosus. Cell. 85:1996;303-336.
7. Sasaki T., Muryoi T., Hatakeyama A., Suzuki M., Sato H., Seino J., et al. Circulating anti-DNA immune complexes in active lupus nephritis. Am J Med. 91:1991;355-362.
8. Mostoslavsky G., Fischel R., Yachimovich N., Yarkoni Y., Rosenmann E., Monestier M., et al. Lupus anti DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol. 31:2001;1221-1227.
9. Cooper G.S., Dooley M.A., Treadwell E.L., St. Clair E.W., Parks C.G., Gilkeson G.S. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 41:1998;1714-1724.
10. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol. 11:1999;352-356.
11. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett. 112-113:2000;421-432.
12. Ahmad Y.A., Bruce I.M. Genetic epidemiology: systemic lupus erythematosus. Arthritis Res. 3:2001;331-336.
13. Wakeland E.K., Liu K., Graham R.R., Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:2001;397-408.
14. McMurray R.W. Sex hormones in the pathogenesis of systemic lupus erythematosus. Front Biosci. 6:2001;E193-E206.
15. Gulko P., Winchester R. Kammer G.M., Tsokos G.C. Lupus: Molecular and cellular pathogenesis. 1999;101-123 Humana Press, Totowa.
16. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosis. Arthritis Rheum. 41:1998;1241-1250.
17. Tsokos G.C., Kammer G.M. Molecular aberrations in human systemic lupus erythematosus. Mol Med Today. 6:2000;418-424.
18. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science. 283:1999;1277-1278.
19. Rider V., Abdou N.I. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol. 1:2001;1009-1024.
20. Ansel J.C., Mountz J., Steinberg A.D., DeFabo E., Green I. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol. 85:1985;181-186.
21. Griffiths M.M., Sawitzke A.D., Harper D.S., McCall S., Reese V.R., Cannon G.W. Exacerbation of collagen-induced arthritis in rats by rat cytomegalovirus is antigen-specific. Autoimmunity. 18:1994;177-187.
22. Liossis S.N., Kovacs B., Dennis G., Kammer G.M., Tsokos G.C. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest. 98:1996;2549-2557.
23. Liossis S.N., Ding X.Z., Dennis G.J., Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest. 101:1998;1448-1457.
24. Khan I.U., Laxminarayana D., Kammer G.M. Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 production. J Immunol. 166:2001;7600-7605.
25. Kammer G.M., Tsokos G.C. Abnormal T lymphocyte signal transduction in systemic lupus erythematosus. Curr Dir Autoimmun. 5:2002;131-150.
26. Redpath S., Angulo A., Gascoigne N.R., Ghazal P. Immune checkpoints in viral latency. Annu Rev Microbiol. 55:2001;531-560.
27. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
28. Yu M., Johnson J.M., Tuohy V.K. Generation of autonomously pathogenic neoautoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J Neurosci Res. 45:1996;463-470.
29. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Neville K.L., Yauch R.L., et al. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J Neurovirol. 3:(Suppl 1):1997;S62-S65.
30. Fujinami R.S., Oldstone M.B. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res. 8:1989;3-15.
31. Wucherpfennig K.W., Strominger J.L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med. 181:1995;597-601.
32. Davies J.M. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol. 75:1997;113-126.
33. Janeway C.A., Travers P., Walport M., Capra J.D. Immunobiology. The immune system in health and disease. 1999;Churchill Livingstone, Edinburgh. p. 417-27.
34. Naniche D., Oldstone B.A. Generalized immunosuppression: how viruses undermine the immune response. Cell Mol Life Sci. 57:2000;1399-1407.
35. Perl A. Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol. 28:2001;461-464.
36. Sekigawa I., Ogasawara H., Kaneko H., Hishikawa T., Hashimoto H. Retroviruses and autoimmunity. Intern Med. 40:2001;80-86.
37. Adelman M.K., Marchalonis J.J. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol. 102:2002;107-116.
38. Ambrosino C., Palmieri C., Puca A., Trimboli F., Shiavone M., Olimpico F., et al. Physical and functional interaction of the HIV-1 Tat with E2F-4 a transcriptional regulator of mammalian cell cycle. J Biol Chem. 277:2002;31448-31458.
39. Abu-Shakra M., El-Sana S., Margalith M., Sikuler E., Neumann L., Buskila D. Hepatitis B and C viruses serology in patients with SLE. Lupus. 6:1997;543-554.
40. Kato N., Lan K.H., Ono-Nita S.K., Shiratori Y., Omata M. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol. 71:1997;8856-8859.
41. Elsana S., Sikuler E., Yaari A., Shemer-Avni Y., Abu-Shakra M., Buskila D., et al. HCV antibodies in saliva and urine. Med Virol. 55:1998;24-27.
42. Ramos-Casals M., Font J., Garcia-Carasco M., Cervera R., Jiminez S., Trejo O., et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum. 43:2000;2801-2806.
43. Garcia-Carrasco M., Ramos-Casals M., Cervera R., Trejo O., Yague J., Siso A., et al. Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. Semin Arthritis Rheum. 30:2001;366-373.
44. Kwun H.J., Jung E.Y., Ahn J.Y., Lee M.N., Jang K.L. p53-dependent transcriptional repression of p21(waf) by hepatitis C virus NS3. J Gen Virol. 82:2001;2235-2241.
45. Majumder M., Ghosh A.K., Stele R., Ray R., Ray R.B. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol. 75:2001;1401-1407.
46. Danesh F.R., Lynch P., Kanwar Y.S. Lupus membranous glomerulonephritis mimicking hepatitis C-associated nephropathy. Am J Kidney Dis. 39:2002;E19-1407.
47. Kolman J.L., Taylor N., Marshak D.R., Miller G. Ser-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation. Proc Natl Acad Sci USA. 90:1993;10115-10119.
48. Bourillot P.Y., Walter L., Sergeant A., Manet E. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. J Gen Virol. 79:1998;363-370.
49. Adamson A.L., Kenney S. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol. 73:2001;6551-6558.
50. James J.A., Harley J.B., Scofield R.H. Role of viruses in systemic lupus erythematosus and Sjögren syndrome. Curr Opin Rheumatol. 13:2001;370-376.
51. Katz B.Z., Salimi B., Kim S., Nsiah-Kumi P., Wagner-Weiner L. Epstein-Barr virus burden in adolescents with systemic lupus erythematosus. Pediatr Infect Dis. 20:2001;148-153.
52. Verdolini R., Bugatti L., Giangiacomi M., Nicolini M., Filosa G., Cerio R. Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol. 146:2002;877-881.
53. Moens U., Rekvig O.P. Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection. Khalili K., Stoner G.L. Human polyomaviruses: molecular and clinical perspectives. 2001;359-408 Wiley-Liss, New York.
54. Lang D., Stamminger T. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J Virol. 67:1993;323-331.
55. Tsai Y.T., Chiang B.L., Kao Y.F., Hsieh K.H. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int Arch Allergy Immunol. 106:1995;235-240.
56. Lukac D.M., Harel N.Y., Tanese N., Alwine J.C. TAF-like functions of human cytomegalovirus immediate-early proteins. J Virol. 71:1997;7227-7239.
57. Rider J.R., Ollier W.E., Lock R.J., Brookes S.T., Pamphilon D.H. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol. 15:1997;405-409.
58. Hayashi T., Lee S., Ogasawara H., Sekigawa I., Iida N., Tomino Y., et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus. 7:1998;561-564.
59. Egorova O.N., Balabanova R.M., Chuvirov G.N. The significance of determining antibodies to viruses of the Herpesviridae family in rheumatic diseases. in Russian Ter Arkh. 71:1999;57-61.
60. Nawata M., Seta N., Yamada M., Sekigawa I., Lida N., Hashimoto H. Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol. 30:2001;360-362.
61. Zhang C., Shen K., Jiang Z., He X. Early diagnosis and monitoring of active HCMV infection in children with systemic erythematosus. Chin Med J. 114:2001;1309-1312.
62. Gawn J.M., Greaves R.F. Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol. 76:2002;4441-4455.
63. Kubbutat H.G., Vousden K.H. New HPV E6 binding proteins: dangerous liaisons? Trends Microbiol. 6:1998;173-175.
64. Berthier S., Mougin C., Vercherin P., Desmurs H., Gil H., de Wazieres B., et al. Does a particular risk associated with papillomavirus infections exist in women with lupus? in French Rev Med Interne. 20:1999;128-132.
65. Cerutti M.L., Centeno J.M., Goldbaum F.A., de Prat-gay G. Generation of sequence-specific, high affinity anti-DNA antibodies. J Biol Chem. 20:2001;12769-12773.
66. Berns K.I. Parvoviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Fields virology. 1996;2173-2197 Raven Press, New York.
67. Tanaka A., Sugawara A., Sawai K., Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med. 37:1998;708-710.
68. Moore T.L., Bandlamudi R., Alam S.M., Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum. 28:1999;314-318.
69. Trapani S., Ermini M., Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum. 28:1999;319-325.
70. Diaz F., Callazos J., Mendoza F., De La Viuda J.M., Cazallas J., Urkijo J.C., et al. Systemic lupus erythematosus associated with acute parvovirus B19 infection. Clin Microbiol Infect. 8:2002;115-117.
71. Cohen J.I., Strauss S.E. Varicella-zoster virus and its replication. Fields B.N., Knipe D.M., Howley P.M. Fields virology. 1996;2525-2545 Raven Press, New York.
72. Ishikawa O., Abe M., Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 24:1999;327-328.
73. Dörries K. Latent and persistent polyomavirus infection. Khalili K., Stoner G.L. Human polyomaviruses: molecular and clinical perspectives. 2001;197-235 Wiley-Liss, New York.
74. Coleman D.V., Wolfendale M.R., Daniel R.A., Dhanjal N.K., Gardner S.D., Gibson P.E., et al. A prospective study of human polyomavirus infection in pregnancy. Infect Dis. 142:1980;1-8.
75. Markowitz R.B., Eaton B.A., Kubik M.F., Latorra D., McGregor J.A., Dynan W.S. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol. 65:1991;4515-4519.
76. Jin L., Pietropaola V., Booth J.C., Ward K.H., Brown D.W. Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis. Clin Diagn Virol. 3:1995;285-295.
77. Chang D., Wang M., Ou W.C., Lee M.S., Ho H.N., Tsai R.T. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol. 48:1996;95-101.
78. Bendiksen S., Rekvig O.P., Van Ghelue M., Moens U. VP1 DNA sequences of JC and BK viruses detected in urine of systemic lupus erythematosus patients reveals no differences from strains expressed in normal individuals. J Gen Virol. 81:2000;2625-2633.
79. Markowitz R.B., Thompson H.C., Mueller J.F., Cohen J.A., Dynan W.S. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and uninfected subjects. J Infect Dis. 167:1993;13-20.
80. Sundsfjord A., Flaegstad T., Flo R., Spein A.R., Pedersen M., Permin H., et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis. 169:1994;485-490.
81. Agostini H.T., Brubaker G.R., Shao J., Levin A., Ryschkewitsch C.F., Blattner W.A., et al. BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol. 140:1995;1919-1934.
82. Shah K.V., Daniel R.W., Strickler H.D., Goedert J.J. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis. 176:1997;1618-1621.
83. Degener A.M., Pietropaolo V., Di Taranto C., Jin L., Ameglio F., Cordiali-Fei P., et al. Identification of a new control region in the genome of the DDP strain of BK virus isolated from PBMC. J Med Virol. 58:1999;413-419.
84. Taguchi F., Hara K., Kajioka J., Nagaki D. Isolation of BK virus from a patient with systemic lupus erythematosus (SLE). Microbiol Immunol. 23:1979;1131-1132.
85. Chang D., Tsai R.T., Wang M.L., Ou W.C. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. J Med Virol. 48:1996;204-209.
86. Tsai R.T., Wang M., Ou W.C., Lee Y.L., Li S.Y., Fung C.Y., et al. Incidence of JC viruria is higher than that of BK viruria in Taiwan. J Med Virol. 52:1997;253-257.
87. Rekvig O.P., Moens U., Sundsfjord A., Bredholt G., Osei A., Haaheim H., et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen: a molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest. 99:1997;2045-2054.
88. Sundsfjord A., Osei A., Rosenqvist H., Van Ghelue M., Silsand Y., Haga H.J., et al. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis. 180:1999;1-9.
89. Corallini A., Tognon M., Negrini M., Barbanti-Brodano G. Evidence for BK virus as a human tumor virus. Khalili K., Stoner G.L. Human polyomaviruses: molecular and clinical perspectives. 2001;431-460 Wiley-Liss, New York.
90. Del Valle L., Gordon J., Ferrante P., Khalili K. JC virus in experimental and clinical brain tumorigenesis. Khalili G., Stoner G.L. Human polyomaviruses: molecular and clinical perspectives. 2001;409-430 Wiley-Liss, New York.
91. Flægstad T., Fredriksen K., Dahl B., Traavik T., Rekvig O.P. Inoculation with BK virus may break immunological tolerance to histone and DNA antigens. Proc Natl Acad Sci USA. 85:1988;8171-8175.
92. Clever J., Dean D.A., Kasamatsu H. Identification of a DNA binding domain in simian virus 40 capsid proteins Vp2 and Vp3. J Biol Chem. 268:1993;20877-20883.
93. Soussi T. DNA-binding properties of the major structural protein of simian virus 40. J Virol. 59:1986;740-742.
94. Moens U., Seternes O.M., Hey A.W., Silsand Y., Traavik T., Johansen B., et al. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc Natl Acad Sci USA. 92:1995;12393-12397.
95. Moens U., Mathiesen I., Ghelue M.V., Rekvig O.P. Green fluorescent protein modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo. Mol Immunol. 38:2002;505-514.
96. Andreassen K., Bredholt G., Moens U., Bendiksen S., Kauric G., Rekvig O.P. T cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: a molecular basis for anti-DNA antibody production. Eur J Immunol. 29:1999;2715-2728.
97. Andreassen K., Moens U., Nossent H., Marion T.N., Rekvig O.P. Termination of human T cell tolerance to histones by presentation of histones and polyomavirus T-antigen provided that T antigen is complexed with nucleosomes. Arthritis Rheum. 42:1999;2449-2460.
98. Chang D., Cai X., Consigli R.A. Characterization of the DNA binding properties of polyomavirus capsid protein. J Virol. 67:1993;6327-6331.
99. Knowles W.A. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. Khalili K., Stoner G.L. Human polyomaviruses: molecular and clinical perspectives. 2001;527-559 Wiley-Liss, New York.
100. Bredholt G., Olaussen E., Moens U., Rekvig O.P. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen. Footprints of a common molecular and cellular process? Arthritis Rheum. 42:1999;2583-2592.
101. Yoshiike K., Takemoto K.K. Studies with BK virus and monkey lymphotropic papovavirus. Salzman N.P. The papovaviridae. 1986;295-332 Plenum, New York.
102. Deyerle K.L., Subramani S. Human papovavirus BK early gene regulation in nonpermissive cells. Virology. 169:1989;385-396.
103. Ault G.S., Stoner G.L. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J Gen Virol. 73:1992;2669-2678.
104. Iida T., Kitamura T., Guo J., Taguchi F., Aso Y., Nagashima K., et al. Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA. 90:1993;5062-5065.
105. Stoner G.L., Ryschkewitsch C.F. Capsid protein VP1 deletions in JC virus from two AIDS patients with progressive multifocal leukoencephalopathy. J Neurovirol. 1:1995;189-194.
106. Stoner G.L., Agostini H.T., Ryschkewitsch C.F., Baumhefner R.W., Tourtellotte W.W. Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients. Mult Scler. 1:1996;193-199.
107. Agostini H.T., Ryschkewitsch C.F., Stoner G.L. Complete genome of a JC virus genotype type 6 from the brain of an African American with progressive multifocal leukoencephalopathy. J Hum Virol. 1:1998;267-272.
108. Newman J.T., Frisque R.J. Identification of JC virus variants in multiple tissues of pediatric and adult PML patients. J Med Virol. 58:1999;79-86.
109. Moens U., Subramaniam N., Johansen B., Johansen T., Traavik T. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol. 68:1994;2398-2408.
110. Moens U., Van Ghelue M., Johansen B., Seternes O.M. Concerted expression of BK virus large T- and small t-antigens strongly enhances oestrogen receptor-mediated transcription. J Gen Virol. 80:1999;585-594.
111. Haaheim L.R., Halse A.-K., Kvakestad R., Stern B., Normann O., Jonsson R. Serum antibodies from patients with primary Søgren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. Scand J Immunol. 43:1996;115-121.
112. Jaques S., Zaveloff P., Karakelides M., Syed O., Yan H., Taylor D., et al. Expression of Epstein-Barr virus nuclear antigen-1 (EBNA-1) in mouse muscle tissue leads to the production of antibodies to double-stranded DNA (dsDNA). FASEB J. 14:2000;A1209-121.
113. Sundar K., Jaques S., Spatz L., Lee K.H., Gottlieb P. Mice immunized with Epstein-Barr nuclear antigen-1 expressing plasmids secrete antibodies to EBNA-1, dsDNA and Sm. FASEB J. 15:2001;A1058-121.
114. Wichmann I., Garcia-Lozano J.R., Respaldiza N., Gonzalez-Escribano M.F., Nunez-Roldan A. Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus. Hum Immunol. 60:1999;57-62.
115. Kaliyaperumal A., Michaels M.A., Datta S.K. Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol. 168:2002;2530-2537.
116. Dong X., Wang J., Kabir F.N., Shaw M., Reed A.M., Stein L., et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum. 43:2000;85-93.
117. Reeves W.H. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med. 161:1985;18-39.
118. Lee K.J., Dong X., Wang J., Takeda Y., Dynan W.S. Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region. J Immunol. 169:2002;3413-3421.
119. Chou C.H., Wang J., Knuth M.W., Reeves W.H. Role of a major autoepitope in forming the DNA binding site of the p70 (Ku) antigen. J Exp Med. 175:1992;1677-1684.
120. Kuhn H.M., Kromminga A., Flammann H.T., Frey M., Layer P., Arndt R. p53 autoantibodies in patients with autoimmune diseases: a quantitative approach. Autoimmunity. 31:1999;229-235.
121. Garcia-Lozano R., Wichmann I., Garcia A., Sanchez-Roman J., Gonzalez-Escribano F., Nunez-Roldan A. Presence of antibodies to replication protein A in some patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 103:1996;74-76.
122. Abendroth F.D., Peterson S.R., Galman M., Suwa A., Hardin J.A., Dynan W.S. Identification of human autoantibodies to transcription factor IIB. Nucleic Acids Res. 23:1995;2770-2774.
123. Cai Y., Kitajima S., Etoh F., Kinoshita S., Okubo K., Hamasaki N. Autoantibody reactive with the human general transcription factor TFIIF in sera from patients with autoimmune disorders. Clin Exp Immunol. 109:1997;488-494.
124. Yanagidani A., Matsuoka M., Yokoro K., Tanaka H., Numoto M. Identification of human autoantibodies to the transcriptional repressor ZF5. J Autoimmun. 15:2000;75-80.